This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Owens, D. M. Articles by Watt, F. M. Search for Related Content PubMed PubMed Citation Articles by Owens, D. M. Articles by Watt, F. M.

Influence of ß1 Integrins on Epidermal Squamous Cell Carcinoma Formation in a Transgenic Mouse Model

3ß1, but not 2ß1, Suppresses Malignant Conversion¹

Imperial Cancer Research Fund, Keratinocyte Laboratory, London WC2A 3PX, United Kingdom

Although aberrant integrin expression has been documented in many epithelial tumors, little is known about how integrins influence neoplastic progression. To examine this issue, transgenic mice in which the 2ß1 or 3ß1 integrin was expressed in the suprabasal epidermal layers via the involucrin promoter were subjected to skin carcinogenesis. Equal numbers of benign squamous papillomas were observed in transgenic and wild-type animals. However, the frequency of conversion of papillomas to malignant squamous cell carcinomas was much lower in 3ß1 transgenic than in 2ß1 transgenic and wild-type mice. No differences were observed in apoptosis or in the expression of endogenous integrins in transgenic and wild-type papillomas. However, 3ß1 transgenic papillomas displayed a diminished proliferative capacity and were more highly differentiated as judged by BrdUrd incorporation and keratin 10 expression, respectively, than 2ß1 transgenic and wild-type papillomas. Two proteins that associate with 3ß1 and not 2ß1 are extracellular matrix metalloproteinase inducer and CD81. Extracellular matrix metalloproteinase inducer expression correlated inversely with the degree of differentiation in normal epidermis and in transgenic and wild-type papillomas. Up-regulation of CD81 was observed in 100% of wild-type and 88% of 2ß1 transgenic papillomas but in only 25% of 3ß1 transgenic papillomas. CD81 was undetectable in untreated epidermis and strongly expressed in all transgenic and wild-type squamous cell carcinomas. Our results demonstrate that the 3ß1 integrin can suppress malignant conversion, and that the mechanism may involve CD81.

This article has been cited by other articles:

				C. Niemann, D. M. Owens, P. Schettina, and F. M. Watt Dual Role of Inactivating Lef1 Mutations in Epidermis: Tumor Promotion and Specification of Tumor Type Cancer Res., April 1, 2007; 67(7): 2916 - 2921. [Abstract] [Full Text] [PDF]

				V. Pons, C. Peres, J.-M. Teulie, M. Nauze, M. Mus, C. Rolland, X. Collet, B. Perret, A. Gassama-Diagne, and F. Hullin-Matsuda Enterophilin-1 Interacts with Focal Adhesion Kinase and Decreases {beta}1 Integrins in Intestinal Caco-2 Cells J. Biol. Chem., March 5, 2004; 279(10): 9270 - 9277. [Abstract] [Full Text] [PDF]

				Session 6: Stem Cells: Contribution of Stem Cells and Differentiated Cells to Tumours of the Epidermis FIONA M. WATT, CR-UK London Research Institute, London WC2A 3PX, England Toxicol Pathol, January 1, 2004; 32(1): 147 - 148. [PDF]

				C. S. Stipp, T. V. Kolesnikova, and M. E. Hemler EWI-2 regulates {alpha}3{beta}1 integrin-dependent cell functions on laminin-5 J. Cell Biol., December 8, 2003; 163(5): 1167 - 1177. [Abstract] [Full Text] [PDF]

				D. M. Owens, M. R. Romero, C. Gardner, and F. M. Watt Suprabasal {alpha}6{beta}4 integrin expression in epidermis results in enhanced tumourigenesis and disruption of TGF{beta} signalling J. Cell Sci., September 15, 2003; 116(18): 3783 - 3791. [Abstract] [Full Text] [PDF]

				R. M. Hobbs and F. M. Watt Regulation of Interleukin-1{alpha} Expression by Integrins and Epidermal Growth Factor Receptor in Keratinocytes from a Mouse Model of Inflammatory Skin Disease J. Biol. Chem., May 23, 2003; 278(22): 19798 - 19807. [Abstract] [Full Text] [PDF]